WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 6'7601 Infant (under 12 months) mortality rate: 122
GDP / capita (US$): 10'0301 Child (under 5 years) mortality rate: 132

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 72  72  71  71  71  70  71  75 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years 19  19  19  19  19  18  18  18 

Number of reported case

(Click for retrospective incidence data for Dominica)
Diphtheria
Japanese encephalitis
Measles 13 
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Dominica)
Vaccine year result method % card seen                                                
BCG          97  98  99*  99*  99  99  99  65 
DTP1          98  98  96  97  98  98 
DTP3          97  97  98  98  100  99  92  63 
HepB_BD          90 
HepB3          97  97  98  98  100 
Hib3          97  97  98  98  100  46 
JapEnc         
MCV          93  99  99  99*  99*  99  88 
MCV2          91  94  99*  99*  95 
PCV1         
PCV3         
Pol3          96  97  99*  99  99  99  94  53 
Rota1         
Rota_last         
Rubella1          93  99  99  99*  99* 
TT2plus          10  20 
PAB         
VAD1         
YFV          100 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Dominica)
BCG 97  98  98  99  99  99  99  65 
DTP1 98  98  99  99  99  99  97  84 
DTP3 96  97  98  98  99  99  92  63 
HepB3 96  97  98  98  99 
HepB_BD
Hib3 96  97  98  98  99 
MCV 93  99  99  99  99  99  88 
MCV2 91  94  94  95  95 
PCV3
Pol3 96  97  98  99  99  99  94  53 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth-1 year; Yes
DT 2, 4, 6 months; DT is given to children unable to have Pertussis
DTwP 18 months; 3 years;
DTwPHibHep 2, 4, 6 months;
HepB 15 years; +4 weeks; +6 months Yes At birth for children with positive Hep B Mothers.
Influenza 6 months to 5 years; >= 65 years; Yes High risk
MMR 1, 3 years; Yes
OPV 2, 4, 6, 18 months; 3, 10-12 years; Yes
Td 10-12 years;
YF travelers

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  Yes  No  No  Yes  Yes  Yes 
What years does the MYP cover? number   2011-2012      2'009  ongoing  2'007 
Nº of districts with microplans that include activities to raise immunization coverage number  

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  Yes  Yes       

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 43  71  86  100  100     

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  No  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.